|

Molecular Pituitary Imaging Using 18F-FET PET

RECRUITINGN/ASponsored by University of Cambridge
Actively Recruiting
PhaseN/A
SponsorUniversity of Cambridge
Started2024-09-03
Est. completion2026-09-02
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06584123

Summary

The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion criteria

* Participant is willing and able to give informed consent for participation in the study
* Male or female, age 18 or above
* Presence of pituitary adenoma suspected on the basis of clinical/biochemical and/or radiological findings
* Previous 11C-Met-PET/CT

Exclusion criteria

* Inability to give informed consent
* Pregnancy or suspected pregnancy
* Inability to lie supine for 30-60 minutes
* Patient body habitus above scanner dimensions
* Known allergy to intravenous radiographic contrast agents

Conditions2

CancerPituitary Adenoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.